AMCX vs ANGI

AMCX's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given a high Debt/Equity ratio of 1.83. While the stock trades at a deeply discounted valuation (P/E 4.34, Price/Book 0.31), its negative revenue growth (-0.80% YoY) and inconsistent earnings performance undermine long-term viability. The Graham Number of $29.31 suggests significant undervaluation, but the intrinsic value of $11.62 reflects low growth expectations and high risk. Overall, the combination of weak fundamentals, poor insider sentiment, and deteriorating trends makes the stock a high-risk proposition.

ANGI's Piotroski F-Score of 4/9 indicates weak financial health, falling short of the 7-9 threshold for strong stability. The absence of an Altman Z-Score raises concern over potential distress risk, especially given the company's declining revenue and earnings trends. While the Graham Number ($22.13) suggests undervaluation, the intrinsic value estimate ($6.58) and current price ($7.39) imply a modest premium, unsupported by consistent profitability or growth. The stock has underperformed dramatically over the past 5 years, with a 95.6% decline, and recent earnings misses have been severe, averaging a -32.28% surprise over the last four quarters. These factors collectively point to a fundamentally weak and deteriorating business.